TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25374101

Group type: EXPERIMENTAL
Intervention: 40 IU insulin detemir
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23371384

Group type: EXPERIMENTAL
Intervention: Web-based risk appraisal tool
Number of subjects: 15495

Group type: COMPARATOR
Intervention: Control group (no web-based tool)
Number of subjects: 15495
Study: 21340475

Group type: EXPERIMENTAL
Intervention: Melatonin treatment (mean dose 2.69 mg, mean duration 3.1 years)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (general Dutch population of the same age and sex)
Number of subjects: 51
Study: 18823687

Group type: COMPARATOR
Intervention: Placebo/Low-Sodium (LS) diet
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Losartan/High Sodium
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Losartan/Low Sodium (LS)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Losartan/High Sodium plus Hydrochlorothiazide (HCT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Losartan/Low Sodium (LS) plus Hydrochlorothiazide (HCT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combined Losartan plus HCT
Number of subjects: 34
Study: 17381182

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study: 15346093

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg/day)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 10907116

Group type: EXPERIMENTAL
Intervention: Post-load glucose concentrations
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Fasting split proinsulin and 30-min insulin concentrations
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Fasting, split proinsulin and 30-min insulin concentrations
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Plasma glucose 30 min after a glucose load
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Insulin concentrations
Number of subjects: 385
Study: 9278939

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8317386

Group type: EXPERIMENTAL
Intervention: Marine oil supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard formulas (control)
Number of subjects: 0
Study: 3105412

Group type: EXPERIMENTAL
Intervention: Polydioxanone suture (PDS) for colonic anastomoses
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional suture material (silk) for colonic anastomoses
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Polydioxanone suture (PDS) for gastric or small bowel anastomoses
Number of subjects: 98

Group type: COMPARATOR
Intervention: Chromic catgut for gastric or small bowel anastomoses
Number of subjects: 98
Study: 29671705

Group type: EXPERIMENTAL
Intervention: STOPP version 2 criteria
Number of subjects: 206

Group type: COMPARATOR
Intervention: Clinician's application of STOPP version 2
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: STOPP version 2 criteria (systematic application)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Clinician's implicit evaluation
Number of subjects: 206
Study: 31176205

Group type: EXPERIMENTAL
Intervention: Adjuvant IMRT
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 27196566

Group type: EXPERIMENTAL
Intervention: PSAs with integrated affirming text
Number of subjects: 0

Group type: COMPARATOR
Intervention: PSAs without affirming text
Number of subjects: 0
Study: 25981810

Group type: EXPERIMENTAL
Intervention: 200 mg sonidegib
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 800 mg sonidegib
Number of subjects: 230
Study: 24173657

Group type: EXPERIMENTAL
Intervention: Venlafaxine hydrochloride extended release (up to 300 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Fluoxetine hydrochloride (up to 80 mg)
Number of subjects: 21
Study: 21188415

Group type: EXPERIMENTAL
Intervention: Unilateral (UL) maximal voluntary contraction (MVC)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bilateral (BL) maximal voluntary contraction (MVC)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation
Number of subjects: 13
Study: 19295417

Group type: EXPERIMENTAL
Intervention: Telephone support intervention 1 week after surgery
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 228
Study: 17180156

Group type: EXPERIMENTAL
Intervention: Intra‐dialytic parenteral nutrition (IDPN) with exercise
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intra‐dialytic parenteral nutrition (IDPN) alone
Number of subjects: 5
Study: 15084858

Group type: EXPERIMENTAL
Intervention: levofloxacin 0.5%
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ofloxacin 0.3%
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ciprofloxacin 0.3%
Number of subjects: 67
Study: 11997706

Group type: EXPERIMENTAL
Intervention: Dopamine D2-class receptor antagonist sulpiride
Number of subjects: 0
Study: 9602581

Group type: EXPERIMENTAL
Intervention: Isoflurane (0.1 MAC)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Sevoflurane (0.1 MAC)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Desflurane (0.1 MAC)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Sedation score
Number of subjects: 25
Study: 7973964

Group type: EXPERIMENTAL
Intervention: Mechanically elicited electromyograms
Number of subjects: 89

Group type: COMPARATOR
Intervention: Other methods
Number of subjects: 89
Study: 2788222

Group type: EXPERIMENTAL
Intervention: Seventh-grade interventions based on the social influences model
Number of subjects: 7124

Group type: COMPARATOR
Intervention: Other conditions (not specified)
Number of subjects: 7124
Study: 29519133

Group type: EXPERIMENTAL
Intervention: Fentanyl-soaked biodegradable synthetic polyurethane foams packing (50 mcg)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Saline-soaked packing
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Fentanyl-soaked packing
Number of subjects: 152
Study: 27814918

Group type: EXPERIMENTAL
Intervention: Four-tiered echocardiographic analysis (FTEA) method
Number of subjects: 436

Group type: COMPARATOR
Intervention: Conventional diagnostic method
Number of subjects: 436
Study: 25759859

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Persica mouthwash
Number of subjects: 30
Study: 23816755

Group type: EXPERIMENTAL
Intervention: Felodipine combined with irbesartan
Number of subjects: 218

Group type: COMPARATOR
Intervention: Felodipine combined with metoprolol
Number of subjects: 218
Study: 21317777

Group type: EXPERIMENTAL
Intervention: Preincision intravenous normal saline and direct infiltration of dexmedetomidine (1 μg/kg) to the surgical wounds at the end of the surgery (Group P)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Preincision intravenous dexmedetomidine (1 mcg/kg) and direct infiltration of normal saline to the surgical wounds at the end of the surgery (Group D)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Normal saline at both time points (Group N)
Number of subjects: 99
Study: 19571773

Group type: EXPERIMENTAL
Intervention: Oral fluid analysis
Number of subjects: 0
Study: 16179403

Group type: EXPERIMENTAL
Intervention: Local cooling at -4 degrees C/min with bretylium tosylate (BT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local cooling at -0.33 degrees C/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N(G)-nitro-L-arginine methyl ester (L-NAME)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rapid local cooling (-4 degrees C/min) to 24 degrees C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: After 35-45 min of local cooling at BT + saline sites
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: After 35-45 min of local cooling at BT + L-NAME sites
Number of subjects: 0
Study: 15750259

Group type: EXPERIMENTAL
Intervention: Valsartan (an angiotensin II receptor blocker)
Number of subjects: 3000
Study: 11308252

Group type: EXPERIMENTAL
Intervention: Clodronate (1.6 g daily orally) for 3 years
Number of subjects: 61

Group type: COMPARATOR
Intervention: Antioestrogen therapy (tamoxifen 20 mg or toremifene 60 mg daily) for 3 years
Number of subjects: 61

Group type: COMPARATOR
Intervention: Recent HRT users
Number of subjects: 61
Study: 9329386

Group type: EXPERIMENTAL
Intervention: 10 mg MK-677
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 50 mg MK-677
Number of subjects: 9

Group type: COMPARATOR
Intervention: MK-677
Number of subjects: 9
Study: 7933710

Group type: EXPERIMENTAL
Intervention: Schizophrenic group with SPEM dysfunction
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Schizophrenic group without SPEM dysfunction
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 10
Study: 3142943

Group type: EXPERIMENTAL
Intervention: 100 mg rt-PA intravenously over 3 h
Number of subjects: 721

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 721
Study: 4177613

Group type: EXPERIMENTAL
Intervention: Anti-D immunoglobulin (250 mug)
Number of subjects: 662

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 662
Study: 31651213

Group type: EXPERIMENTAL
Intervention: Integrated Psychological Therapy (IPT) + Emotional Management Training (EMT)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 77
Study: 29417768

Group type: EXPERIMENTAL
Intervention: Minimally invasive expandable channel
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional open posterior operation approach
Number of subjects: 48
Study: 25497473

Group type: COMPARATOR
Intervention: escitalopram+placebo
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: bupropion-sustained-release+escitalopram
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: venlafaxine-extended-release+mirtazapine
Number of subjects: 665
Study: 23192403

Group type: EXPERIMENTAL
Intervention: Operative treatment (nonobese)
Number of subjects: 1190

Group type: COMPARATOR
Intervention: Operative treatment (obese)
Number of subjects: 1190

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment (nonobese)
Number of subjects: 1190

Group type: COMPARATOR
Intervention: Nonoperative treatment (obese)
Number of subjects: 1190

Group type: EXPERIMENTAL
Intervention: Operative treatment (both groups)
Number of subjects: 1190
Study: 17144515

Group type: EXPERIMENTAL
Intervention: FDT
Number of subjects: 57

Group type: COMPARATOR
Intervention: SAP
Number of subjects: 57
Study: 12857467

Group type: EXPERIMENTAL
Intervention: L-Arginine (L-Arg) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (HIRI group)
Number of subjects: 0
Study: 10365899

Group type: EXPERIMENTAL
Intervention: Pyloriset EIA‐G New (a quantitative enzyme‐linked immunosorbent assay)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 115
Study: 8983917

Group type: EXPERIMENTAL
Intervention: Endurance training (T)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Endurance training (T) + Selenium supplementation (Sel)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acute exercise (E)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of acute exercise (E) + endurance training (T)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of acute exercise (E) + endurance training (T) + selenium supplementation (Sel)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Selenium supplementation (Sel)
Number of subjects: 24
Study: 2012724

Group type: EXPERIMENTAL
Intervention: Measures concerning arterial diameter and lumen volume
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Measures concerning edge irregularity and localized stenosis
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Mean diameter and square root of lumen volume
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Overall measures
Number of subjects: 107
Study: 6294793

Group type: EXPERIMENTAL
Intervention: Cefotaxime (2 g daily for 5-10 days, max 12 g in severe cases)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Cefotaxime (2 g daily for 5-10 days)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Cefazolin (2 g daily for 5-10 days)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 477

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 477
Study: 29471266

Group type: EXPERIMENTAL
Intervention: RSV-A genotype detection
Number of subjects: 20359

Group type: EXPERIMENTAL
Intervention: RSV-B genotype detection
Number of subjects: 20359
Study: 28283245

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 25622882

Group type: EXPERIMENTAL
Intervention: Intra-alveolar chlorhexidine (CHX) gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23250911

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV) combined with medications
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-ASV treatment (control group)
Number of subjects: 36
Study: 21564445

Group type: EXPERIMENTAL
Intervention: Involvement of nurse specialists for 1 year
Number of subjects: 384

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Involvement of nurse specialists for 1 year (in patients without baseline anxiety/depression)
Number of subjects: 384
Study: 18366697

Group type: EXPERIMENTAL
Intervention: Use of Data Monitoring Committees (DMCs) in RCTs
Number of subjects: 79396

Group type: EXPERIMENTAL
Intervention: Interim analysis without DMC involvement
Number of subjects: 79396

Group type: EXPERIMENTAL
Intervention: Recommendations leading to biased results
Number of subjects: 79396

Group type: EXPERIMENTAL
Intervention: Sample size re-estimation
Number of subjects: 79396

Group type: EXPERIMENTAL
Intervention: Changes to trial endpoints
Number of subjects: 79396
Study: 15899448

Group type: EXPERIMENTAL
Intervention: Hydrophilic acrylic single-piece IOL
Number of subjects: 106

Group type: COMPARATOR
Intervention: Hydrophobic acrylic single-piece IOL
Number of subjects: 106
Study: 12974971

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 0
Study: 10755201

Group type: EXPERIMENTAL
Intervention: Quinapril (40 mg)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Captopril (3 x 50 mg)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 8689766

Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 0
Study: 2021872

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) for 6 weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Budesonide (Bu) for 6 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no specific control mentioned)
Number of subjects: 16
Study: 6588271

Group type: EXPERIMENTAL
Intervention: Hemofiltration (HF)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Both HF and HD
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Plasma ammonia levels
Number of subjects: 6
Study: 31935579

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ranolazine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31338790

Group type: EXPERIMENTAL
Intervention: Cognitive intervention (Michael's game) alongside standard treatment for psychosis
Number of subjects: 172

Group type: COMPARATOR
Intervention: Standard treatment for psychosis
Number of subjects: 172
Study: 27607571

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 14671

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14671

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 14671

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 14671
Study: 27070732

Group type: EXPERIMENTAL
Intervention: Severe cannabis use (31-240 joints at baseline and 10-196 joints at follow-up)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High (reducing) cannabis use (31-240 joints at baseline and 0-9 joints at follow-up)
Number of subjects: 60
Study: 25134001

Group type: EXPERIMENTAL
Intervention: Glucose-fructose beverage (1.55 g·min, 2:1 ratio)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Moderate-glucose beverage (1.03 g·min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-glucose beverage (1.55 g·min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (artificially sweetened)
Number of subjects: 8
Study: 22042731

Group type: EXPERIMENTAL
Intervention: Short waiting period (n=23)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Long waiting period (n=37)
Number of subjects: 60
Study: 19507291

Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention intervention
Number of subjects: 392

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 392
Study: 17475386

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 68
Study: 15665657

Group type: EXPERIMENTAL
Intervention: Soy isoflavone supplementation (110 mg/day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Soy isoflavone supplementation
Number of subjects: 19
Study: 12521500

Group type: EXPERIMENTAL
Intervention: Membrane stripping
Number of subjects: 137

Group type: COMPARATOR
Intervention: Gentle cervical examination (Control)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Membrane stripping and Gentle cervical examination (Control)
Number of subjects: 137
Study: 10193289

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dexamethasone 8 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg with Dexamethasone 8 mg
Number of subjects: 120
Study: 8594966

Group type: EXPERIMENTAL
Intervention: Lidocaine (6 mg/kg body weight)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Prilocaine (7 mg/kg body weight)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Ohmeda BIOX 3700e
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Critikon Oxyshuttle
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Nellcor N 180
Number of subjects: 171
Study: 2234207

Group type: EXPERIMENTAL
Intervention: Semiannual screening by X-ray and sputum cytology
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Screening at a 3-year interval
Number of subjects: 6000
Study: 702289

Group type: EXPERIMENTAL
Intervention: Suspension A
Number of subjects: 12

Group type: COMPARATOR
Intervention: Suspension B (Control)
Number of subjects: 12
Study: 28007717

Group type: EXPERIMENTAL
Intervention: 1 g of PUFA twice daily
Number of subjects: 561

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 561
Study: 25810469

Group type: EXPERIMENTAL
Intervention: Family-based intervention with community health worker (promotora) model and entertainment-education component
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Family-based intervention
Number of subjects: 180
Study: 24304987

Group type: EXPERIMENTAL
Intervention: Unilateral approach for bilateral decompression
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional laminectomy
Number of subjects: 60
Study: 21509675

Group type: EXPERIMENTAL
Intervention: Lamivudine (100 mg per day) combined with Chinese medicine (CM) treatment for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lamivudine (100 mg per day) alone for 12 weeks
Number of subjects: 120
Study: 19538406

Group type: EXPERIMENTAL
Intervention: Natural childbirth preparation with psychoprophylactic training (breathing and relaxation techniques)
Number of subjects: 2151

Group type: COMPARATOR
Intervention: Standard antenatal education without psychoprophylactic training
Number of subjects: 2151

Group type: EXPERIMENTAL
Intervention: Natural childbirth preparation with psychoprophylactic training
Number of subjects: 2151
Study: 16780253

Group type: EXPERIMENTAL
Intervention: Static sport
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Dynamic sport
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study: 15302053

Group type: COMPARATOR
Intervention: Normothermic CPB (n=30, temp=35 degrees C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Differential temperature management (Cobra cannula)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (Normothermic CPB and Differential temperature management)
Number of subjects: 60
Study: 11176398

Group type: EXPERIMENTAL
Intervention: Total androgen blockade for 1 month before prostatectomy
Number of subjects: 147

Group type: COMPARATOR
Intervention: No total androgen blockade
Number of subjects: 147

Group type: COMPARATOR
Intervention: Total androgen blockade
Number of subjects: 147
Study: 9322446

Group type: EXPERIMENTAL
Intervention: Enoximone (0.25 mg/kg bolus, cumulative dose 0.5 mg/kg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 8227480

Group type: EXPERIMENTAL
Intervention: Trandolapril 1 mg once daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: Trandolapril 0.5 mg twice daily
Number of subjects: 31
Study: 3510525

Group type: EXPERIMENTAL
Intervention: Diltiazem-SR 240 mg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diltiazem-SR 360 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29664681

Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol with ExT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol without ExT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol with or without ExT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol plus ExT
Number of subjects: 0

Group type: COMPARATOR
Intervention: SMBM plus placebo
Number of subjects: 0
Study: 27344296

Group type: EXPERIMENTAL
Intervention: Radium-223 (50 kBq/kg, intravenous injection) every 4 weeks for six cycles
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study: 24009292

Group type: EXPERIMENTAL
Intervention: Divided dosing (BD) prednisolone
Number of subjects: 22
Study: 22424346

Group type: EXPERIMENTAL
Intervention: Early operation (≤1 month)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Late operation (>1 month)
Number of subjects: 36